Jiangsu Kanion Pharmaceutical Co., Ltd.
- Country
- 🇨🇳China
- Ownership
- Public, Subsidiary
- Established
- 1996-05-08
- Employees
- 5.4K
- Market Cap
- -
- Website
- http://shop.kanion.com
A Phase I Clinical Trial Evaluating the Safety, Tolerability and Pharmacokinetics of AAPB for Injection
- Conditions
- Acute Ischemic Stroke (AIS)
- Interventions
- Drug: Single dose, AAPB by injection, intravenous drip.Other: Single dose, placebo, intravenous drip.Drug: Multiple dosing, AAPB for injection, intravenous dripOther: Multiple dosing, placebo, IV drip
- First Posted Date
- 2024-11-08
- Last Posted Date
- 2024-11-08
- Lead Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd
- Target Recruit Count
- 56
- Registration Number
- NCT06679998
- Locations
- 🇨🇳
Beijing Tiantan Hospital, Capital Medical University, Beijing, Beijing, China
A Prospective Cohort Study of Compound Nanxing Zhitong Ointment
- Conditions
- Chronic Musculoskeletal Pain
- First Posted Date
- 2022-01-21
- Last Posted Date
- 2022-01-21
- Lead Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd
- Target Recruit Count
- 3000
- Registration Number
- NCT05201365
Evaluate the Safety, Tolerability and Pharmacokinetic Profile of TPN672 Tablets Maleate in Patients With Schizophrenia
- First Posted Date
- 2022-01-14
- Last Posted Date
- 2022-01-14
- Lead Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd
- Target Recruit Count
- 62
- Registration Number
- NCT05192304
- Locations
- 🇨🇳
Shanghai Mental Health Center, Shanghai, Shanghai, China
A Pilot Study for Ginkgolides Meglumine Injection Skin Testing.
- Conditions
- Allergy
- Interventions
- Drug: 0.1mg/ml Ginkgolides Meglumine InjectionDrug: 1mg/ml Ginkgolides Meglumine InjectionDrug: 5mg/ml Ginkgolides Meglumine Injection
- First Posted Date
- 2014-10-15
- Last Posted Date
- 2014-12-02
- Lead Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd
- Target Recruit Count
- 149
- Registration Number
- NCT02264535
- Locations
- 🇨🇳
Second Affiliated Hospital of Tianjin University of TCM, Tianjin, China
A Drug-Drug Interaction Study To Investigate The Ginkgolides Meglumine Injection To Alter The Pharmacokinetics Of Midazolam
- Conditions
- Pharmacokinetics
- Interventions
- First Posted Date
- 2014-09-09
- Last Posted Date
- 2014-10-20
- Lead Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd
- Target Recruit Count
- 15
- Registration Number
- NCT02233972
- Locations
- 🇨🇳
The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, Jiangsu, China
Preliminary Study of Pharmacokinetics of Ginkgolides Meglumine Injection.
- First Posted Date
- 2014-01-27
- Last Posted Date
- 2014-07-15
- Lead Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd
- Target Recruit Count
- 4
- Registration Number
- NCT02046031
- Locations
- 🇨🇳
The first affiliated hospital with Nanjing Medical University, Nanjing, Jiangsu, China
A Randomized, Placebo-Controlled, Double-blind Study of Tianshu Capsule in the Treatment of Migraine.
- First Posted Date
- 2014-01-14
- Last Posted Date
- 2016-04-15
- Lead Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd
- Target Recruit Count
- 947
- Registration Number
- NCT02035111
- Locations
- 🇨🇳
Langfang hospital of Traditional Chinese Medicine, Langfang, Hebei, China
🇨🇳Tangshan TCM Hospital, Tangshan, Hebei, China
🇨🇳Wuhan sixth hospital, Wuhan, Hubei, China
Multi-center Clinical Trials of Sanjie Analgesic Capsule in Treating Endometriosis
- First Posted Date
- 2014-01-09
- Last Posted Date
- 2014-11-19
- Lead Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd
- Target Recruit Count
- 400
- Registration Number
- NCT02031523
- Locations
- 🇨🇳
Beijing ChaoYang Hospital, Beijing, Beijing, China
🇨🇳The General Hospital of People's Liberation Army, Beijing, Beijing, China
🇨🇳The Maternal and Child Health Hospital of Hunan Province, Changsha, Hunan, China
A Safety Study of Ginkgolides Meglumine Injection in the Treatment of Ischemic Stroke.
- First Posted Date
- 2013-10-09
- Last Posted Date
- 2014-12-24
- Lead Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd
- Target Recruit Count
- 6300
- Registration Number
- NCT01958957
- Locations
- 🇨🇳
CN027, Baotou, China
🇨🇳CN043, Changchun, China
🇨🇳CN051, Anyang, China
Effect of KYG0395 on Primary Dysmenorrhea
- Conditions
- Primary Dysmenorrhea
- Interventions
- Drug: high dose KYG0395Drug: lower dose KYG0395Drug: Placebo
- First Posted Date
- 2012-04-30
- Last Posted Date
- 2019-03-26
- Lead Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd
- Target Recruit Count
- 280
- Registration Number
- NCT01588236
- Locations
- 🇺🇸
Coastal Connecticut Research, New London, Connecticut, United States
🇺🇸Benchmark Research, Austin, Texas, United States
🇺🇸Columbus Center for Women's Health Research, Columbus, Ohio, United States